Conneqt Health Limited - Asset Resilience Ratio
Conneqt Health Limited (CQT) has an Asset Resilience Ratio of 0.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Conneqt Health Limited total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Conneqt Health Limited's Asset Resilience Ratio has changed over time. See Conneqt Health Limited shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Conneqt Health Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Conneqt Health Limited market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Conneqt Health Limited maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Conneqt Health Limited Industry Peers by Asset Resilience Ratio
Compare Conneqt Health Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Conneqt Health Limited (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Conneqt Health Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$9.32 Million ≈ $6.60 Million |
-- |
| 2024-06-30 | 38.50% | AU$4.87 Million ≈ $3.45 Million |
AU$12.65 Million ≈ $8.95 Million |
+0.27pp |
| 2023-06-30 | 38.23% | AU$5.56 Million ≈ $3.93 Million |
AU$14.54 Million ≈ $10.29 Million |
+29.81pp |
| 2022-06-30 | 8.43% | AU$1.04 Million ≈ $738.22K |
AU$12.38 Million ≈ $8.76 Million |
-22.92pp |
| 2021-06-30 | 31.35% | AU$3.53 Million ≈ $2.50 Million |
AU$11.26 Million ≈ $7.97 Million |
-- |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more